These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6334099)

  • 1. 2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.
    Sidi Y; Mitchell BS
    J Clin Invest; 1984 Nov; 74(5):1640-8. PubMed ID: 6334099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells.
    Sidi Y; Hudson JL; Mitchell BS
    Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
    Mann GJ; Fox RM
    J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
    J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential metabolism of guanine nucleosides by human lymphoid cell lines.
    Mitchell BS; Sidi Y
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):427-31. PubMed ID: 3875100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and mechanistic studies on the toxicity of deoxyguanosine for the in vitro proliferation and differentiation of human peripheral blood B lymphocytes.
    Scharenberg JG; Spaapen LJ; Rijkers GT; Duran M; Staal GE; Zegers BJ
    Eur J Immunol; 1986 Apr; 16(4):381-7. PubMed ID: 3084280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of deoxyguanosine on human lymphocyte function. II. Analysis of the interference with B lymphocyte differentiation in vitro.
    Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Duran M; Stoop JW; Zegers BJ
    J Immunol; 1984 May; 132(5):2318-23. PubMed ID: 6425400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes.
    Simmonds HA; Goday A; Morris GS; Brolsma MF
    Biochem Pharmacol; 1984 Mar; 33(5):763-70. PubMed ID: 6424679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts.
    Kazmers IS; Mitchell BS; Dadonna PE; Wotring LL; Townsend LB; Kelley WN
    Science; 1981 Dec; 214(4525):1137-9. PubMed ID: 6795718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages.
    Scharenberg JG; Rijkers GT; Spaapen LJ; Toebes EA; Rijksen G; Duran M; Staal GE; Zegers BJ
    Int J Immunopharmacol; 1988; 10(6):675-86. PubMed ID: 2974022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 8-aminoguanosine on the toxicity of guanosine and deoxyguanosine for malignant and normal lymphoid cells.
    van der Kraan PM; van Zandvoort PM; De Abreu RA; Bakkeren JA
    J Leukoc Biol; 1988 Jul; 44(1):46-50. PubMed ID: 3164750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.
    Osborne WR; Scott CR
    Biochem J; 1983 Sep; 214(3):711-8. PubMed ID: 6312962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
    Boss GR; Pilz RB
    J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
    Scharenberg JG; Spaapen LJ; Rijkers GT; Wadman SK; Staal GE; Zegers BJ
    Adv Exp Med Biol; 1986; 195 Pt B():191-9. PubMed ID: 3094325
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro.
    Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Wadman SK; Stoop JW; Zegers BJ
    J Immunol; 1984 May; 132(5):2311-7. PubMed ID: 6425399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
    Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
    J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts.
    Ullman B; Martin DW
    J Clin Invest; 1984 Sep; 74(3):951-5. PubMed ID: 6332120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat model of purine nucleoside phosphorylase deficiency.
    Osborne WR; Barton RW
    Immunology; 1986 Sep; 59(1):63-7. PubMed ID: 3019875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency.
    Albert D; Bluestein HG; Willis RC; Nette K; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):501-9. PubMed ID: 6428752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.